Stock chart
Analyses on Sure-Tech (4)
- March 12, 2026March 12, 2026
- Follow-up
Sure-Tech: Has Antidote Become the Core Asset, or Is This Still Mostly a SAFE Mark?
Antidote has already become Sure-Tech's core asset in portfolio weight and in the quality of its business story, but the uplift in value still rests materially on SAFE and conversion mechanics rather than on a transparent capital-market price backed by audited financial statemen…
- Follow-up
Sure-Tech: When the Control Dispute Reaches Capital Allocation Itself
At Sure-Tech, the control fight is no longer only about governance tone or control over the general partner. It now reaches the partnership's funding route, the authority to make follow-on investments in portfolio companies, and the use of partnership cash to fund the legal proc…
- Follow-up
Sure-Tech: How Much of GeoX's Value Really Depends on a Major Client and a Legal Reset
GeoX remains in Sure-Tech's books at NIS 7.2 million not because its value is already stable, but because the valuer weighted a reset case in which a very material customer lands and the legal process calms down. This is the value of a narrow path, not a comfortable floor.
Sure-Tech Investments in 2025: The Value Is Still in the Portfolio, but Access to It Has Narrowed
Sure-Tech enters 2026 with a portfolio that still carries meaningful reported value, but after the GeoX markdown, cash erosion, and the deeper control dispute, the key question is no longer how much value sits in the books but how much of it is genuinely accessible to public uni…
